Cumberland Pharmaceuticals Inc. (CPIX)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Specialty Pharmaceutical Products	37.87M	39.55M	42.01M	35.99M	37.44M
Specialty Pharmaceutical Products Growth	-4.26%	-5.85%	16.75%	-3.89%	8.88%
Total	37.87M	39.55M	42.01M	35.99M	37.44M
Total Growth	-4.26%	-5.85%	16.75%	-3.89%	8.88%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
United States	35.17M	38.45M	40.51M	33.79M	35.04M
United States Growth	-8.54%	-5.08%	19.91%	-3.58%	6.55%
Outside The United States	2.70M	1.10M	1.50M	2.20M	2.40M
Outside The United States Growth	145.45%	-26.67%	-31.82%	-8.33%	60.00%
Total	37.87M	39.55M	42.01M	35.99M	37.44M
Total Growth	-4.26%	-5.85%	16.75%	-3.89%	8.88%

Source: S&P Global Market Intelligence.